EHA Library - The official digital education library of European Hematology Association (EHA)

BONE MARROW METASTASIS: A CASE SERIES
Author(s): ,
Siew Lian Chong
Affiliations:
Haematology Department,Ampang Hospital,Selangor,Malaysia
,
Rui Jeat Fann
Affiliations:
Haematology Department,Ampang Hospital,Selangor,Malaysia;Faculty of Medicine and Health Sciences,Universiti Tunku Abdul Rahman,Selangor,Malaysia
,
Kah Wai Ngan
Affiliations:
Pathology Department,Serdang Hospital,Selangor,Malaysia
,
Asral Wirda Ahmad Asnawi
Affiliations:
Haematology Department,Ampang Hospital,Selangor,Malaysia;Faculty of Medicine and Health Sciences,Universiti Sains Islam Malaysia,Seremban,Malaysia
,
Veena Selvaratnam
Affiliations:
Haematology Department,Ampang Hospital,Selangor,Malaysia
Sen Mui Tan
Affiliations:
Haematology Department,Ampang Hospital,Selangor,Malaysia
EHA Library. Chong S. 06/09/21; 324168; PB1489
Dr. Siew Lian Chong
Dr. Siew Lian Chong
Contributions
Abstract

Abstract: PB1489

Type: Publication Only

Session title: Bone marrow failure syndromes incl. PNH - Clinical

Background

In bone marrow metastasis, the search of primary tumor is important as prompt treatment dictates prognosis of patient.  However, site of primary tumor remains elusive in 10-30% of metastatic cancer despite extensive search.  

Aims
At Clinical Referral Haematology Laboratory, Hospital Ampang, which is the tertiary referral laboratory for all hospitals within the Ministry of Health in Malaysia, we performed a retrospective review on the cases with a trephine diagnosis of metastatic carcinoma between 2010-2020.

Methods

A bone marrow trephine biopsy was performed based on patients' clinical presentation and cytopenia from full blood count. We analyzed each report individually and extracted the patients’ clinical data from our cases and report, including the primary tumor and or possible metastasis site as well as survival rates.

Results

There were 14 cases of tumors metastatic to the bone marrow comprising of 9 women and 5 men, with median age of 60.3-year-old. Metastasis was made upon a bone marrow trephine biopsy was performed. Preliminary of 6 cases who we manage to identify the site of primary tumor whereas the rest of the cases with unknown primary bone marrow metastasis.

Conclusion

Bone marrow metastasis is an infrequent event. Close collaboration between clinician and pathologist is essential for diagnosis, identification of tumour subtype and even primary site of tumour for management and prognostication for cancer of unknown primary.   Outcome of unfavourable cancer of unknown primary is poor even with recommended treatment.

Keyword(s): Bone marrow involvement, Metastasis

Abstract: PB1489

Type: Publication Only

Session title: Bone marrow failure syndromes incl. PNH - Clinical

Background

In bone marrow metastasis, the search of primary tumor is important as prompt treatment dictates prognosis of patient.  However, site of primary tumor remains elusive in 10-30% of metastatic cancer despite extensive search.  

Aims
At Clinical Referral Haematology Laboratory, Hospital Ampang, which is the tertiary referral laboratory for all hospitals within the Ministry of Health in Malaysia, we performed a retrospective review on the cases with a trephine diagnosis of metastatic carcinoma between 2010-2020.

Methods

A bone marrow trephine biopsy was performed based on patients' clinical presentation and cytopenia from full blood count. We analyzed each report individually and extracted the patients’ clinical data from our cases and report, including the primary tumor and or possible metastasis site as well as survival rates.

Results

There were 14 cases of tumors metastatic to the bone marrow comprising of 9 women and 5 men, with median age of 60.3-year-old. Metastasis was made upon a bone marrow trephine biopsy was performed. Preliminary of 6 cases who we manage to identify the site of primary tumor whereas the rest of the cases with unknown primary bone marrow metastasis.

Conclusion

Bone marrow metastasis is an infrequent event. Close collaboration between clinician and pathologist is essential for diagnosis, identification of tumour subtype and even primary site of tumour for management and prognostication for cancer of unknown primary.   Outcome of unfavourable cancer of unknown primary is poor even with recommended treatment.

Keyword(s): Bone marrow involvement, Metastasis

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies